Literature DB >> 27955810

Synthesis of 2-methyl-1,4-naphthoquinones with higher gamma-glutamyl carboxylase activity than MK-4 both in vitro and in vivo.

Cees Vermeer1, Cynthia van 't Hoofd2, Marjo H J Knapen2, Sofia Xanthoulea2.   

Abstract

Vitamin K is the collective term for compounds that share a 2-methyl-1,4-naphthoquinone ring, but differ in the side-chain at the 3-position. We synthesized novel 2-methyl-1,4-naphthoquinone derivatives with different side chain length at the 3-position. Derivatives with C-14 and C-16 tails showed the highest in vitro bioactivity resulting in 2.5 and 2-fold higher carboxylated osteocalcin synthesis in MG63 cells than menaquinone-4 (MK-4, form of vitamin K2). Longer side chain lengths resulted in lower bioactivity. The in vivo vitamin K activity of the C-14 tail derivative was further tested in WKY rats receiving a vitamin K-deficient diet that resulted in a 40% decrease of prothrombin activity. The C-14 tail derivative was able to counteract the effects on vitamin K deficiency induced by the diet and resulted in the complete restoration of prothrombin activity. Compared to naturally occurring forms of vitamin K, synthetic vitamin K derivatives may have higher bioactivity and different pharmacological characteristics that are more favorable for use as supplements or in clinical settings.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  2-Methyl-1,4-naphthoquinone; Menaquinone; Osteocalcin; Phylloquinone; Vitamin K

Mesh:

Substances:

Year:  2016        PMID: 27955810     DOI: 10.1016/j.bmcl.2016.11.073

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

Review 1.  Vitamin K and bone.

Authors:  Maria Fusaro; Maria Cristina Mereu; Andrea Aghi; Giorgio Iervasi; Maurizio Gallieni
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

2.  A novel vitamin K derived anticoagulant tolerant to genetic variations of vitamin K epoxide reductase.

Authors:  Xuejie Chen; Yizhou Liu; Natsuko Furukawa; Da-Yun Jin; G Paul Savage; Darrel W Stafford; Yoshitomo Suhara; Craig M Williams; Jian-Ke Tie
Journal:  J Thromb Haemost       Date:  2021-01-22       Impact factor: 5.824

Review 3.  New aspects of microbial vitamin K2 production by expanding the product spectrum.

Authors:  Zimeng Zhang; Linxia Liu; Chuan Liu; Yumei Sun; Dawei Zhang
Journal:  Microb Cell Fact       Date:  2021-04-13       Impact factor: 5.328

Review 4.  Vitamin K as a Diet Supplement with Impact in Human Health: Current Evidence in Age-Related Diseases.

Authors:  Dina C Simes; Carla S B Viegas; Nuna Araújo; Catarina Marreiros
Journal:  Nutrients       Date:  2020-01-03       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.